Abstract:Photodynamic therapy (PDT) of cancer is a clinically approved, minimally invasive therapeutic approach, combining PDT drug (photosensitizer, PS), molecular oxygen and light to produce cytotoxicity via reactive oxygen species (ROS), which are generated by the light excited PS. Most of the PS molecules fluoresce under excitation with light and fluorescence imaging (FLI) can be employed to evaluate their biodistribution and assess the intratumoral delivery before the therapeutic light application. Light absorption can also be utilized to track a PS by photoacoustic imaging (PAI). However, an excitation of the PS during assessment of its biodistribution through FLI or PAI results in premature photobleaching and causes toxicity. An involvement of a separate fluorescent (luminescent) or photoacoustic imaging probe, which provides imaging contrast in combination with PS without excitation of the latter, can allow for "see-and-treat" approach with FLI/PAI guided PDT. On the other hand, it is well-known that near-infrared (NIR) light is able to penetrate relatively deeper in comparison with visible light, due to reduced absorption and scattering. In addition to the conventional NIR window (NIR-I, ~700-950 nm), other transparency windows for biological tissues have recently been identified at ~1000-1700 nm (NIR-II), benefiting optical bioimaging due to the reduced tissue scattering and autofluorescence. Multiple NIR-II imaging probes are currently introduced both for luminescence and photoacoustic bioimaging, providing the significantly improved signal to noise ratio (SNR), imaging depth and resolution. Their combinations with PS are also being increasingly reported, though no review on this hot topic currently exists. Herein, a state-of-the-art in NIR photoluminescence (including fluorescence) and photoacoustic imaging guided PDT is presented. NIR-I and NIR-II spectral ranges are considered, along with both molecular and nanoparticle formulations for imaging guided PDT. It is expected that this review will provide a solid foundation for future translational studies in the domain of NIR imaging guided photodynamic therapy and drug delivery.

Single-Component Photochemical Afterglow Near-Infrared Luminescent Nano-Photosensitizers: Bioimaging and Photodynamic Therapy

Organic Nanoparticles with Persistent Luminescence for in Vivo Afterglow Imaging-Guided Photodynamic Therapy

Molecular And Nanoparticulate Agents For Photodynamic Therapy Guided By Near Infrared Imaging

Highly Efficient Multifunctional Organic Photosensitizer with Aggregation-Induced Emission for In Vivo Bioimaging and Photodynamic Therapy

A Highly Efficient and Photostable Photosensitizer with Near-Infrared Aggregation-Induced Emission for Image-Guided Photodynamic Anticancer Therapy

Precise Molecular Engineering of Photosensitizers with Aggregation‐Induced Emission over 800 Nm for Photodynamic Therapy

Bright Aggregation-Induced Emission Nanoparticles for Two-Photon Imaging and Localized Compound Therapy of Cancers

Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy

Red-to-near-infrared self-reporting photosensitizers with high photostability for photodynamic therapy

Molecular Engineering Design of Enhanced Donor-Acceptor Therapeutic Reagent for Efficient Image-Guided Photodynamic Therapy

In Vivo Bioimaging and Photodynamic Therapy Based on Two-Photon Fluorescent Conjugated Polymers Containing Dibenzothiophene-S,S-dioxide Derivatives.

A near-infrared bioprobe with aggregation-induced emission feature for in vitro photodynamic therapy

Type I Photosensitizer Based on AIE Chromophore Tricyano-Methylene-pyridine for Photodynamic Therapy

Advancing Two‐Photon Photodynamic Therapy Over NIR‐II Excitable Conjugated Microporous Polymer with NIR‐I Emission

Phototherapeutic applications of benzophenone-containing NIR-emitting photosensitizers based on different receptor modulations

One Stone, Two Birds: High-Brightness Aggregation-Induced Emission Photosensitizers for Super-Resolution Imaging and Photodynamic Therapy.

Stable Organic Photosensitizer Nanoparticles with Absorption Peak beyond 800 Nanometers and High Reactive Oxygen Species Yield for Multimodality Phototheranostics

Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy

Near-infrared-II Triggered Inorganic Photodynamic Nanomedicines for Deep-Tissue Therapy

Bright and White Light-Triggered Aggregation-Induced Emission Nanoparticles Prepared in Miniemulsions for Photodynamic Theranostics

Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models.